As you know, in multiple sclerosis, most of our patients are females, so now, because we have many treatments, we have improved a lot the quality of life of our patients, so that now, when the patients are reaching the age of 55, many of them have a very good quality of life. The problem is that all of these women will have menopause, and in menopause, we have symptoms that overlap with the symptoms of multiple sclerosis, so that symptoms like fatigue, urinary alterations, sleep disorders are the same for MS and for menopause, so that the patients, when they have these overlapping symptoms, have more symptoms, and now that we have recognized this thing, this problem, so we have decided that perhaps when we treat menopause, the patients will have less symptoms, so that we can improve the quality of life of our patients...
As you know, in multiple sclerosis, most of our patients are females, so now, because we have many treatments, we have improved a lot the quality of life of our patients, so that now, when the patients are reaching the age of 55, many of them have a very good quality of life. The problem is that all of these women will have menopause, and in menopause, we have symptoms that overlap with the symptoms of multiple sclerosis, so that symptoms like fatigue, urinary alterations, sleep disorders are the same for MS and for menopause, so that the patients, when they have these overlapping symptoms, have more symptoms, and now that we have recognized this thing, this problem, so we have decided that perhaps when we treat menopause, the patients will have less symptoms, so that we can improve the quality of life of our patients. So, the message will be, first, to try to see if the patients have menopause symptoms, and when they have them, to treat these menopause symptoms with hormones, and later, the patient will have less problems with multiple sclerosis.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.